Leukemia Research
Volume 23, Issue 8 , Pages 719-721 , August 1999

Secondary acute myeloid leukemia 4 years after the diagnosis of hairy cell leukemia: case report and review of the literature

Received 12 January 1999 ,Accepted 15 March 1999.

References 

  1. Bouroncle BA. Leukemia reticuloendotheliosis (hairy cell leukemia). Blood. 1979;53:412
  2. Bouroncle BA. Thirty-five years in the progress of hairy cell leukemia. Leuk. Lymp. 1994;14 (Suppl 1):1
  3. Yam LT, Li CY, Lam KW. Tartrate-resistant acid phosphatase isoenzyme in the reticulum cells of leukemic reticuloendotheliosis. New Engl. J. Med. 1971;284:357
  4. Visser L, Shaw A, Slupsky J, Vos H, Poppema S. Monoclonal antibodies reactive with hairy cell leukemia. Blood. 1989;74:320
  5. Jansen J, LeBien TW, Kersey TW. The phenotype of neoplastic cells of hairy cell leukemia studied with monoclonal antibodies. Blood. 1982;59:609
  6. Kurzrock R, Strom SS, Estey E, O’Brien S, Keating M, Jiang H, et al. Second cancer risk in hairy cell leukemia: analysis of 350 patients. J. Clin. Oncol. 1997;15:1803
  7. Jacobs RH, Vokes EE, Golomb HM. Second malignancies in hairy cell leukemia. Cancer. 1985;56:1462
  8. Spielberger RT, Dickstein JI, Le Beau MM, Larson RA, Daly KM, Vardiman HW, et al. Acute myeloid leukaemia following interferon-alfa treatment of hairy cell leukaemia. Br. J. Haematol. 1993;83:519
  9. Saven A, Piro L. Treatment of hairy cell leukemia. Blood. 1992;79:1111
  10. Jaiyesimi IA, Kantarjian HM, Estey EH. Advances in therapy for hairy cell leukemia. A review. Cancer. 1993;72:5
  11. Catovsky D, Matutes E, Talavera JG, O’Connor NTJ, Johnson SAN, Emmett E, et al. Long term results with 2′-deoxycoformycin in hairy cell leukemia. Leuk. Lymph. 1994;14(Suppl. 1):109
  12. Quesada JR, Reuben J, Manning JT, Hersh EM, Gutterman JU. Alpha interferon for induction of remission in hairy cell leukemia. New Engl. J. Med. 1984;310:15
  13. Piro LD, Carrera CJ, Carson DA, Beutler E. Lasting remission in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. New Engl. J. Med. 1990;322:1117
  14. Estey EH, Kurzrock R, Kantarjian HM, O’Brien S, McRedie KB, Beran M, et al. Treatmant of hairy cell leukemia with 2-chlorodeoxyadenosine (2CDA). Blood. 1992;79:882
  15. Seymour JF, Estey EH, Keating MJ, Kurzrock R. Response to interferon-α in patients with hairy cell leukemia relapsing after treatment with 2-chlorodeoxyadenosine. Leukemia. 1995;9:929
  16. Tallman MS, Hakimian D, Rademaker AW, Zanzig C, Wollins E, Rose S, et al. Relapse of hairy cell leukemia after 2-chlorodeoxyadenosine: long-term follow-up of the Northwestern University experience. Blood. 1996;88:1954
  17. Saven A, Piro LD, Carrera CJ, Carson DA, Beutler E. Hairy cell leukemia: new understanding of biology and treatment. Cancer Treat. Res. 1993;64:15
  18. Frassoldati A, Lamparelli T, Federico M, Annino L, Capnist G, Pagnucco G, et al. Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL). Leuk. Lymph. 1994;13:307
  19. Pawson R, A’Hern R, Catovsky D. Second malignancy in hairy cell leukemia: no evidence of increased incidence after treatment with interferon alpha. Leuk. Lymph. 1996;22:103
  20. Demeter J, Turbucz P, Lehoczky D, Porzsolt F. Considerations on the pathogenesis of acute myeloid leukaemia in a splenectomized hairy cell leukaemia patient treated with interferon-alpha. Br. J. Haematol. 1994;86:236
  21. Albain KS, Le Beau MM, Vardiman JW, Golomb HM, Rowley JD. Development of dysmyelopoietic syndrome in hairy cell leukemia patient treated with chlorambucil: cytogenetic and morphologic evaluation. Cancer Genet. Cytogenet. 1983;8:107
  22. Cheson BD. Infectious and immunosuppressive complications of purine analog therapy. J. Clin. Oncol. 1995;13:2431
  23. Carrera CJ, Piro LD, Saven A, Cox K, Beutler E, Carson DA, et al. Restoration of lymphocyte subsets following 2-chlorodeoxyadenosine remission induction in hairy cell leukemia. Blood. 1990;76:260
  24. Juliusson G, Liliemark J. Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2-chloro-2′-deoxyadenosine (CdA): relation to opportunistic infections. Blood. 1992;79:888

PII: S0145-2126(99)00090-9

Leukemia Research
Volume 23, Issue 8 , Pages 719-721 , August 1999

Article Tools